azacitidine has been researched along with B16 Melanoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bassermann, F; Dahl, S; Haas, T; Heidegger, S; Poeck, H; Wintges, A | 1 |
| Achberger, S; Alcazar, O; Aldrich, W; Hu, Z; Negrotto, S; Saunthararajah, Y; Triozzi, P | 1 |
| Achberger, S; Alcazar, O; Aldrich, W; Ponnazhagan, S; Saunthararajah, Y; Triozzi, PL | 1 |
| Battistini, A; Belardelli, F; Fragale, A; Gabriele, L; Lucarini, V; Mattei, F; Sanchez, M; Scala, S; Schiavoni, G; Sestili, P; Sistigu, A; Spada, M; Spadaro, F | 1 |
| Ahmed, A; Chong, H; Daniels, G; Diaz, RM; Holmen, S; Kottke, T; Melcher, A; Sanchez-Perez, L; Thompson, J; Vile, RG | 1 |
| Bergin, OE; Brown, R; Byrne, A; Culhane, AC; Currid, CA; Dervan, PA; Easty, DJ; Esteller, M; Fox, EJ; Fraga, MF; Gallagher, WM; Hughes, L; Kelly, ZD; McArdle, L; McDonnell, S; Moss, C; Murphy, AA; Nolan, IM; O'Mahony, F; Plumb, JA; Rafferty, M; Stallings, RL | 1 |
| Altomonte, M; Colizzi, F; Coral, S; Cortini, E; Di Giacomo, AM; Fonsatti, E; Fratta, E; Maio, M; Nardi, G; Natali, PG; Nicotra, MR; Pezzani, L; Sigalotti, L; Spessotto, A | 1 |
| Baylin, SB; Eguchi, S; Esteller, M; Fraga, MF; Fuks, F; Griffioen, AW; Hellebrekers, DM; Hoebers, NT; Jair, KW; van Engeland, M; Viré, E | 1 |
| Bhattacharya, M; Chakraborty, AK; Chakraborty, D; Chatterjee, A; Funasaka, Y; Pawelek, J; Sousa, Jde F | 1 |
| Bae, SI; Beaulieu, N; Borden, EC; Cherkassky, L; Leaman, DW; Lindner, D; MacLeod, AR; Reu, FJ | 1 |
| Bosenberg, M; Bradbury, CM; Curley, DP; Duraisamy, S; Hobbs, C; Muthusamy, V; Nelson, B | 1 |
| Adams, EG; Bhuyan, BK; Folz, BA; Smith, KS | 1 |
| Alvarez, E; Elliott, BE; Houghton, AN; Kerbel, RS | 1 |
13 other study(ies) available for azacitidine and B16 Melanoma
| Article | Year |
|---|---|
Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice.
Topics: Animals; Azacitidine; Chemoradiotherapy; Disease Models, Animal; Drug Synergism; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Receptors, Cell Surface; Signal Transduction; Treatment Outcome | 2021 |
Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Base Sequence; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor Proteins; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Sequence Analysis, DNA; SOX9 Transcription Factor; Tetrahydrouridine; Tumor Suppressor Protein p53; Up-Regulation | 2012 |
Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Combined Modality Therapy; Cytokines; Decitabine; Dose-Response Relationship, Drug; Female; Humans; Immunotherapy; Interleukin-2; Killer Cells, Natural; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Toll-Like Receptor 9 | 2012 |
IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.
Topics: Animals; Azacitidine; CD4 Lymphocyte Count; Chemokines; Decitabine; Dendritic Cells; Disease Progression; Humans; Interferon Regulatory Factors; Interleukin-17; Interleukins; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor Cross-Talk; Receptors, Chemokine; Spleen; T-Lymphocytes; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor B; Vascular Endothelial Growth Factor Receptor-2 | 2012 |
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo.
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; CD8-Positive T-Lymphocytes; Combined Modality Therapy; DNA Methylation; gp100 Melanoma Antigen; Immunotherapy, Adoptive; Interferon-gamma; Intramolecular Oxidoreductases; Melanocytes; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Nude; Monophenol Monooxygenase; Neoplasm Proteins; Perforin; Pore Forming Cytotoxic Proteins; Tumor Escape; Vaccination; Vaccines, DNA | 2005 |
Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
Topics: Animals; Azacitidine; Biomarkers, Tumor; Cell Cycle Proteins; Decitabine; Disease Progression; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Melanoma, Experimental; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; RNA, Messenger; RNA, Neoplasm; Skin Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications.
Topics: Animals; Antibody Formation; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; Female; Gene Expression; Histocompatibility Antigens Class I; HLA-A1 Antigen; HLA-A2 Antigen; Humans; Immunotherapy; Melanoma-Specific Antigens; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Tumor Cells, Cultured; Vaccination; Xenograft Model Antitumor Assays | 2006 |
Angiostatic activity of DNA methyltransferase inhibitors.
Topics: Acetylation; Angiogenesis Inhibitors; Animals; Azacitidine; Cell Movement; Cytidine; DNA Modification Methylases; Endothelial Cells; Enzyme Inhibitors; Gene Expression; Histones; Humans; Hydroxamic Acids; Insulin-Like Growth Factor Binding Protein 3; Melanoma, Experimental; Mice; Mice, Mutant Strains; Neovascularization, Pathologic; Neovascularization, Physiologic; Thrombospondin 1 | 2006 |
GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Consensus Sequence; Decitabine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Macrophages, Peritoneal; Melanoma, Experimental; Mice; Mice, Inbred DBA; Molecular Sequence Data; N-Acetylglucosaminyltransferases; Neoplasm Metastasis; Phenotype; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcription, Genetic | 2006 |
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Modification Methylases; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Interferon-alpha; Interferon-beta; Interferons; Intracellular Signaling Peptides and Proteins; Kidney Neoplasms; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Proteins; Polymerase Chain Reaction; Transplantation, Heterologous; Up-Regulation | 2006 |
Epigenetic silencing of novel tumor suppressors in malignant melanoma.
Topics: Animals; Azacitidine; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Genetic Predisposition to Disease; Homeodomain Proteins; Humans; Intracellular Signaling Peptides and Proteins; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Syk Kinase; Transfection; Transplantation, Heterologous; Tumor Suppressor Proteins | 2006 |
Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Azacitidine; Benzofurans; Caffeine; Cell Survival; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Cyclohexanecarboxylic Acids; Cyclohexenes; Decitabine; Deoxyadenosines; DNA; Dose-Response Relationship, Drug; Drug Synergism; Duocarmycins; Indoles; Melanoma, Experimental; Melphalan; Mutagens; Organoplatinum Compounds; Pentoxifylline; Tumor Cells, Cultured | 1995 |
Heritable high frequency modulation of antigen expression in neoplastic cells exposed to 5-aza-2'-deoxycytidine or hydroxyurea: analysis and implications.
Topics: Animals; Antigens, Neoplasm; Azacitidine; Decitabine; DNA, Neoplasm; Histocompatibility Antigens; Humans; Hydroxyurea; Mammary Neoplasms, Experimental; Melanoma, Experimental; Methylation; Mice; Tumor Cells, Cultured | 1988 |